Category: DCT
Decentralized clinical trials (DCTs) are transforming the way we approach clinical research by enabling more flexible and patient-centric methodologies. As companies embrace these trials for everything from supplements to skincare products, ensuring compliance in DCTs becomes essential. This blog will explore the critical elements of compliance in decentralized clinical trials and offer strategies to navigate these evolving landscapes successfully. What Are Decentralized Clin
By Ben Brockman
Decentralized clinical trials (DCTs) have revolutionized the way clinical research is conducted. By utilizing technology to reach participants remotely, these trials have opened doors to faster enrollment, greater diversity, and enhanced convenience for both researchers and participants. However, as with any technology-driven process, data security in decentralized clinical trials has become a critical concern. Protecting sensitive health information (PHI) while ensuring com
By Ben Brockman
Clinical trials are no longer just for pharmaceuticals. Today, health, wellness, and CPG brands rely on clinical research to validate product performance, support marketing claims, and build consumer trust. As research methods evolve, brands are increasingly choosing between centralized clinical trials, decentralized clinical trials, or a mix of both. Understanding the difference matters because the trial model you choose affects cost, timelines, participant diversity, and th
By Ben Brockman
Decentralized clinical trials are redefining how research is conducted, bringing participation directly to people’s homes, and breaking down the traditional barriers of location, time, and access. At the heart of this transformation is telehealth: a powerful enabler of remote communication, monitoring, and data collection. In this article, we explore how telehealth is reshaping clinical trials, highlight its benefits and challenges, and examine what the future holds for this
By Ben Brockman